 LOS ANGELES, June 14, 2021 GLOBE NEWSWIRE -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that the FDA has accepted a Pre-IND Investigational New Drug request for a potential functional cure or treatment of HIV. Written comments are expected this Fall. 